Related Experiment Video

Updated: Oct 3, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Gene therapy and pharmaceutical modulation of apoptosis

Y Chandrashekhar1, S Sen

  • 1Department of Medicine, University of Minnesota Medical School, Veterans Affairs Medical Center, Minneapolis, 55417, USA. shekh003@maroon.tc.umn.edu

Cardiology Clinics
|January 15, 2002
PubMed

Insights

Apoptosis, programmed cell death, plays a role in cardiovascular disease progression. Modulating apoptosis in animal models shows promise for tissue salvage and improved function, suggesting future therapeutic potential.

Area of Science:

  • Cardiovascular Medicine
  • Cell Biology
  • Pathophysiology

Background:

  • Apoptosis (programmed cell death) is observed in cardiovascular disease.
  • Current methods for detecting apoptosis require enhancement, and its precise role in disease progression is not fully elucidated.
  • Evidence suggests apoptosis may significantly contribute to the advancement of cardiovascular conditions.

Purpose of the Study:

  • To explore the potential of modulating apoptosis as a therapeutic strategy for cardiovascular disease.
  • To evaluate the preliminary efficacy of apoptosis modulation in preclinical models.

Main Methods:

  • Review of existing evidence on apoptosis in cardiovascular disease.
  • Analysis of preliminary data from animal models investigating the effects of apoptosis modulation.
  • Assessment of therapeutic compounds designed to modulate apoptosis.

Main Results:

  • Preliminary data indicate that apoptosis can be modulated in animal models of cardiovascular disease.
  • Apoptosis modulation in these models was associated with improved tissue salvage and functional outcomes.
  • Specific compounds for apoptosis modulation are available for clinical consideration.

Conclusions:

  • Apoptosis modulation demonstrates significant potential for preventing or ameliorating cardiovascular disease.
  • Further research, including human studies, is necessary to address current limitations and fully realize therapeutic benefits.
  • Despite the need for more data, targeting apoptosis represents a promising future direction in cardiovascular medicine.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...